1. KMT2D deficiency enhances the anti-cancer activity of L48H37 in pancreatic ductal adenocarcinoma
   Si-Si Li et al, 2019, World Journal of Gastrointestinal Oncology CrossRef
2. A competent bidrug loaded water soluble chitosan derivative for the effective inhibition of breast cancer
   Nivethaa E A K et al, 2020, Scientific Reports CrossRef
3. Low dose Emodin induces tumor senescence for boosting breast cancer chemotherapy via silencing NRARP
   Cong Zu et al, 2018, Biochemical and Biophysical Research Communications CrossRef
4. Disruption of CTCF Boundary at HOXA Locus Promote BET Inhibitors’ Therapeutic Sensitivity in Acute Myeloid Leukemia
   Jie Zha et al, 2020, Stem Cell Reviews and Reports CrossRef
5. Differential regulation of Lipocalin 2 (LCN2) in doxorubicin-resistant 4T1 triple negative breast cancer cells
   Steffen K. Meurer et al, 2020, Cellular Signalling CrossRef
6. Lipocalin-2 promotes breast cancer brain metastasis by enhancing tumor invasion and modulating brain microenvironment
   Yang Zhao et al, 2024, Frontiers in Oncology CrossRef
7. Encapsulation for breast cancer treatment
   Zoe Hancox et al, 2023, Principles of Biomaterials Encapsulation : Volume Two CrossRef
8. LCN2: Versatile players in breast cancer
   Yuxiang Bao et al, 2024, Biomedicine & Pharmacotherapy CrossRef